BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Therapix Biosciences Plans Preclinical Study to Evaluate Opioid-Sparing Effects of Two Innovative Synthetic Cannabinoids

  Therapix plans to initiate a preclinical study during the fourth quarter to evaluate the opioid-sparing effect of these compounds in a rat model.

  November 10, 2017

   · 

  5 min read
• Drug Development

  X4 Pharmaceuticals Presents Clinical Data Demonstrating Immune Activation Through CXCR4 Pathway With X4P-001-IO

  The data, primarily generated from biopsies of tumors from melanoma patients, demonstrated important changes in the tumor microenvironment.

  November 10, 2017

   · 

  5 min read
• Biotech Bay

  Veeva Systems Release: Industry Research Shows 97% of Companies to Increase Use of Real-World Patient Data for More Accurate Decision-Making

  November 10, 2017

   · 

  6 min read
• A*STAR IME’s New Multi-Chip Fan-Out Wafer Level Packaging Development Line to Drive Innovation and Growth in Semiconductor Industry

  The IoT is set to become the next growth driver for the semiconductor industry, as demand for internet-connected devices continues to soar.

  November 10, 2017

   · 

  7 min read
• Drug Development

  Blueprint Medicines Announces New Data From Ongoing Phase I Clinical Trial of BLU-285 in Patients With Advanced Gastrointestinal Stromal Tumors Showing Strengthened Clinical Activity Across Spectrum of KIT and Pdgfrα Genotypes

  The data confirm and build upon data previously presented for BLU-285 in patients with advanced GIST, demonstrating robust clinical activity and a favorable safety profile.

  November 10, 2017

   · 

  15 min read
• Deals

  Ajinomoto Acquires Cambrooke Therapeutics

  With this acquisition, Cambrooke gains access to Ajinomoto’s global nutrition and ingredient sciences expertise, as well as proven flavor and texture-enhancing R&D capabilities.

  November 10, 2017

   · 

  3 min read
• Lone Star Bio

  Healthcare Analytics Start-Up Sensio AIR Wins CES 2018 Innovation Award

  Healthcare analytics start-up Sensio AIR has today announced that it has been named a CES 2018 Innovation Award Honoree for its Sensio AIR allergen tracking device.

  November 10, 2017

   · 

  4 min read
• Drug Development

  Aduro Biotech Announces Promising Preclinical Data That Validate Anti-CTLA-4 Antibody ADU-1604

  Poster #335 to be presented at the 32nd Annual Meeting of the Society for Immunotherapy of Cancer.

  November 10, 2017

   · 

  5 min read
• Business

  IP Veteran Andrew Filler Joins BioSig Technologies’ Board of Directors

  Mr. Filler brings to BioSig over 20 years of experience in intellectual property for technology and medical device companies.

  November 10, 2017

   · 

  4 min read
• Business

  Myriad Collaborates With Department of Veterans Affairs in Large Trial Evaluating the GeneSight Test to Improve Mental Health Outcomes for Veterans

  The 2,000 patient study will leverage GeneSight test to guide therapy selection.

  November 10, 2017

   · 

  9 min read